PDT Partners’s Ventyx Biosciences VTYX Stock Holding History

PDT Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-120,502	Closed	-$663K	–	758
2024 Q1	$663K	Buy	+120,502	New	+$551K	0.06%	404

Other funds holding VTYX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PDT Partners's VTYX Position: Q2 2024 in Review

PDT Partners sold out of Ventyx Biosciences (VTYX) in Q2 2024, closing a stake of 120,502 shares — an estimated $663K sold.

PDT Partners first reported a position in VTYX in Q1 2024 and held it in 1 quarter. The position peaked at $663K in Q1 2024. 117 funds tracked by Wall St. Rank hold VTYX as of Q2 2024.

PDT Partners reported no remaining Ventyx Biosciences position as of Q2 2024 after selling out during the quarter.
PDT Partners sold 120,502 Ventyx Biosciences shares in Q2 2024, an estimated $663K.
PDT Partners first reported a position in Ventyx Biosciences in Q1 2024 and held it in 1 quarter.
PDT Partners's Ventyx Biosciences position peaked at $663K in Q1 2024.
117 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.